Skip to main content
padlock icon - secure page this page is secure

RANKL expression in a case of follicular lymphoma

Buy Article:

$59.00 + tax (Refund Policy)

Barcala V, Ruybal P, Garcia Rivello H., Waldner C, Ascione A, Mongini C. RANKL expression in a case of follicular lymphoma. Eur J Haematol 2003: 70: 417–419. © Blackwell Munksgaard 2003. Abstract:

The TNF-family molecule, RANKL, is a key regulator of bone remodeling and essential for the development and activation of osteoclasis. Bone involvement signals diesease activity in non-Hodgkin's lymphoma and influences the progenesis. The molecular mechanism and soluble factors involved in osteoclastic activation in haematological malignancies remain unclear except for Multiple Myeloma and Adult T-cell Leukemia. The aim of this paper is to report the first case of Follicular Lymphoma with bone involvement displaying an aberrant expression of RANKL in malignant cells. The detection of RANKL in Follicullar Lymphoma may help to prevent bone lesion in patients by determining an appropriate treatment.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: RANKL; flow cytometry; follicular lymphoma; osteoporosis

Document Type: Research Article

Affiliations: 1: Hospital Italiano de Buenos Aires – CITOMLAB, Argentina; 2: Laboratorio de Inmunología celular y molecular (cefybo-conicet), Buenos Aires, Argentina; 3: Servicio de Anatomía Patológica, Hospital Italiano de Buenos Aires, Argentina and 4: Laboratorio Central, Hospital Italiano de Buenos Aires, Argentina

Publication date: June 1, 2003

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more